These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29069988)

  • 1. Bariatric surgery reduces fasting total fatty acids and increases n-3 polyunsaturated fatty acids in morbidly obese individuals.
    Hovland A; Nestvold T; Bohov P; Trøseid M; Aukrust P; Berge RK; Waage-Nielsen E; Retterstøl K; Lappegård KT
    Scand J Clin Lab Invest; 2017 Dec; 77(8):628-633. PubMed ID: 29069988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive lifestyle intervention provides rapid reduction of serum fatty acid levels in women with severe obesity without lowering omega-3 to unhealthy levels.
    Lin C; Andersen JR; Våge V; Rajalahti T; Mjøs SA; Kvalheim OM
    Clin Obes; 2016 Aug; 6(4):259-67. PubMed ID: 27334055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of dietary Fatty acids in multiple biological and psychological functions, in morbidly obese subjects.
    Chalut-Carpentier A; Pataky Z; Golay A; Bobbioni-Harsch E
    Obes Surg; 2015 Jun; 25(6):1031-8. PubMed ID: 25373924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbid obesity and type 2 diabetes alter intestinal fatty acid uptake and blood flow.
    Koffert J; Ståhle M; Karlsson H; Iozzo P; Salminen P; Roivainen A; Nuutila P
    Diabetes Obes Metab; 2018 Jun; 20(6):1384-1390. PubMed ID: 29352513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-week omega-3 polyunsaturated fatty acids supplementation for liver left lateral section volume reduction in individuals with morbid obesity undergoing bariatric surgery: A double blind, multicenter, randomized placebo-controlled trial.
    Iannelli A; Fontas E; Grec L; Nocca D; Robert M; Schiavo L; Schneck AS
    Int J Surg; 2022 May; 101():106614. PubMed ID: 35417778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between specific Fatty acids of serum lipids and serum high sensitivity C- reactive protein levels in morbidly obese women.
    Kaska L; Mika A; Stepnowski P; Proczko M; Ratnicki-Sklucki K; Sledzinski T; Goyke E; Swierczynski J
    Cell Physiol Biochem; 2014; 34(4):1101-8. PubMed ID: 25228402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in fatty acid metabolism in response to obesity surgery combined with dietary counseling.
    Walle P; Takkunen M; Männistö V; Vaittinen M; Käkelä P; Ågren J; Schwab U; Lindström J; Tuomilehto J; Uusitupa M; Pihlajamäki J
    Nutr Diabetes; 2017 Sep; 7(9):e285. PubMed ID: 28869586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery.
    García-Fuentes E; García-Almeida JM; García-Arnés J; Rivas-Marín J; Gallego-Perales JL; González-Jiménez B; Cardona I; García-Serrano S; Garriga MJ; Gonzalo M; de Adana MS; Soriguer F
    Obes Surg; 2006 Sep; 16(9):1179-88. PubMed ID: 16989702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients.
    Iannelli A; Martini F; Schneck AS; Ghavami B; Baudin G; Anty R; Gugenheim J
    Obes Surg; 2013 Nov; 23(11):1761-5. PubMed ID: 23686653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bariatric surgery reduces risk factors for development of type 2 diabetes mellitus in morbidly obese, nondiabetic patients.
    Nestvold TK; Nielsen EW; Lappegård KT
    Metab Syndr Relat Disord; 2013 Dec; 11(6):441-6. PubMed ID: 24044780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery.
    Wolf RM; Steele KE; Peterson LA; Zeng X; Jaffe AE; Schweitzer MA; Magnuson TH; Wong GW
    J Clin Endocrinol Metab; 2016 May; 101(5):2211-7. PubMed ID: 26982010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle changes followed by bariatric surgery lower inflammatory markers and the cardiovascular risk factors C3 and C4.
    Nestvold TK; Nielsen EW; Ludviksen JK; Fure H; Landsem A; Lappegård KT
    Metab Syndr Relat Disord; 2015 Feb; 13(1):29-35. PubMed ID: 25329451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin.
    García de la Torre N; Rubio MA; Bordiú E; Cabrerizo L; Aparicio E; Hernández C; Sánchez-Pernaute A; Díez-Valladares L; Torres AJ; Puente M; Charro AL
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4276-81. PubMed ID: 18713823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative hypoxemia in morbidly obese patients with and without obstructive sleep apnea undergoing laparoscopic bariatric surgery.
    Ahmad S; Nagle A; McCarthy RJ; Fitzgerald PC; Sullivan JT; Prystowsky J
    Anesth Analg; 2008 Jul; 107(1):138-43. PubMed ID: 18635479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in SCD gene DNA methylation after bariatric surgery in morbidly obese patients are associated with free fatty acids.
    Morcillo S; Martín-Núñez GM; García-Serrano S; Gutierrez-Repiso C; Rodriguez-Pacheco F; Valdes S; Gonzalo M; Rojo-Martinez G; Moreno-Ruiz FJ; Rodriguez-Cañete A; Tinahones F; García-Fuentes E
    Sci Rep; 2017 Apr; 7():46292. PubMed ID: 28393901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of dropout and bariatric surgery in Icelandic morbidly obese female patients.
    Benediktsdottir A; Halldorsson TI; Bragadottir GJ; Gudmundsson L; Ramel A
    Obes Res Clin Pract; 2016; 10(1):63-9. PubMed ID: 25892541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgery.
    Pek SLT; Cheng AKS; Lin MX; Wong MS; Chan EZL; Moh AMC; Sum CF; Lim SC; Tavintharan S
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3029. PubMed ID: 29883055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of bariatric surgery and lifestyle interventions on plasma levels of Lp(a) and fatty acids.
    Berk KA; Borgeraas H; Narverud I; Mulder MT; Øyri LKL; Verhoeven AJM; Småstuen MC; Bogsrud MP; Omland T; Hertel JK; Gjevestad E; Nordstrand N; Holven KB; Hjelmesæth J
    Lipids Health Dis; 2022 Dec; 21(1):145. PubMed ID: 36577984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients.
    Brandacher G; Winkler C; Aigner F; Schwelberger H; Schroecksnadel K; Margreiter R; Fuchs D; Weiss HG
    Obes Surg; 2006 May; 16(5):541-8. PubMed ID: 16687019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.